Gutzwiller, Sabine
Novartis (Switzerland)
3 papers on CoChat
Most cited papers
- Verified
Phase I/Ib Clinical Trial of Sabatolimab, an Anti‐TIM‐3 Antibody, Alone and in Combination with Spartalizumab, an Anti‐PD‐1 Antibody, in Advanced Solid Tumors
Curigliano, G., Gelderblom, H., Mach, N., Doi, T., Tai, D., Forde, P. M., Sarantopoulos, J., Bedard, P. L., Lin, C.-C., Hodi, F. S., et al. (2021) · Clinical Cancer Research
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 362
- Verified
Genomic and proteomic profiling reveals reduced mitochondrial function and disruption of the neuromuscular junction driving rat sarcopenia
Ibebunjo, C., Chick, J. M., Kendall, T., Eash, J. K., Li, C., Zhang, Y., Vickers, C., Wu, Z., Clarke, B. A., Shi, J., et al. (2013) · Molecular and Cellular Biology
Muscle Physiology and DisordersNutrition and Health in Aging
Cited by 267
- Verified
Blockade of Metallothioneins 1 and 2 Increases Skeletal Muscle Mass and Strength
Summermatter, S., Bouzan, A., Pierrel, E., Melly, S., Stauffer, D., Gutzwiller, S., Nolin, E., Dornelas, C., Fryer, C., Leighton-Davies, J., et al. (2017) · Molecular and Cellular Biology
Muscle Physiology and DisordersNutrition and Health in Aging
Cited by 66
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free